ReWalk granted Nasdaq compliance extension to March 30, 2024 citing CMS rule catalyst

Lifeward Ltd.

Panel extended bid price compliance deadline from Jan 31 to March 30, 2024.
Must close at $1.00+ for 10 consecutive business days by March 30, 2024.
Extension sought to allow CMS to finalize home health rule including exoskeletons in Medicare.
Company may implement reverse stock split to maintain Nasdaq listing if needed.
Risk of delisting remains if compliance not achieved by extended deadline.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.